Annual SGA
$18.95 M
+$11.19 M+143.98%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual SGA is $18.95 million, with the most recent change of +$11.19 million (+143.98%) on December 31, 2023.
- During the last 3 years, ELVN annual SGA has risen by +$17.88 million (+1658.35%).
- ELVN annual SGA is now at all-time high.
Performance
ELVN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$5.81 M
+$33.00 K+0.57%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly SGA is $5.81 million, with the most recent change of +$33.00 thousand (+0.57%) on September 30, 2024.
- Over the past year, ELVN quarterly SGA has dropped by -$207.00 thousand (-3.44%).
- ELVN quarterly SGA is now -3.44% below its all-time high of $6.02 million, reached on March 31, 2024.
Performance
ELVN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$749.06 M
-$85.21 M-12.84%
September 30, 2024
Summary
- As of February 7, 2025, ELVN TTM SGA is -$749.06 million, with the most recent change of -$85.21 million (-12.84%) on September 30, 2024.
- Over the past year, ELVN TTM SGA has dropped by -$769.50 million (-3765.76%).
- ELVN TTM SGA is now -1557.14% below its all-time high of -$45.20 million.
Performance
ELVN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ELVN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +144.0% | -3.4% | -3765.8% |
| 3 y3 years | +1658.3% | +28.0% | -7108.4% |
| 5 y5 years | +1658.3% | +28.0% | -7108.4% |
ELVN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +342.1% | -3.4% | +438.5% | -1557.1% | at low |
| 5 y | 5-year | at high | +1658.3% | -3.4% | +438.5% | -1557.1% | at low |
| alltime | all time | at high | +1658.3% | -3.4% | +438.5% | -1557.1% | at low |
Enliven Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.81 M(+0.6%) | $22.43 M(+5.5%) |
| Jun 2024 | - | $5.78 M(-4.0%) | $21.26 M(+4.0%) |
| Mar 2024 | - | $6.02 M(+24.7%) | $20.43 M(+7.8%) |
| Dec 2023 | $18.95 M(+144.0%) | $4.82 M(+3.9%) | $18.95 M(+17.8%) |
| Sep 2023 | - | $4.64 M(-6.2%) | $16.10 M(+10.6%) |
| Jun 2023 | - | $4.95 M(+9.1%) | $14.56 M(+36.2%) |
| Mar 2023 | - | $4.54 M(+130.8%) | $10.69 M(+37.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $7.77 M(+81.2%) | $1.97 M(-36.7%) | $7.77 M(+5.9%) |
| Sep 2022 | - | $3.10 M(+187.8%) | $7.33 M(+73.4%) |
| Jun 2022 | - | $1.08 M(-33.4%) | $4.23 M(+34.3%) |
| Mar 2022 | - | $1.62 M(+5.7%) | $3.15 M(+105.7%) |
| Dec 2021 | $4.29 M(+297.8%) | - | - |
| Dec 2021 | - | $1.53 M | $1.53 M |
| Dec 2020 | $1.08 M | - | - |
FAQ
- What is Enliven Therapeutics annual SGA?
- What is the all time high annual SGA for Enliven Therapeutics?
- What is Enliven Therapeutics annual SGA year-on-year change?
- What is Enliven Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly SGA year-on-year change?
- What is Enliven Therapeutics TTM SGA?
- What is the all time high TTM SGA for Enliven Therapeutics?
- What is Enliven Therapeutics TTM SGA year-on-year change?
What is Enliven Therapeutics annual SGA?
The current annual SGA of ELVN is $18.95 M
What is the all time high annual SGA for Enliven Therapeutics?
Enliven Therapeutics all-time high annual SGA is $18.95 M
What is Enliven Therapeutics annual SGA year-on-year change?
Over the past year, ELVN annual SGA has changed by +$11.19 M (+143.98%)
What is Enliven Therapeutics quarterly SGA?
The current quarterly SGA of ELVN is $5.81 M
What is the all time high quarterly SGA for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly SGA is $6.02 M
What is Enliven Therapeutics quarterly SGA year-on-year change?
Over the past year, ELVN quarterly SGA has changed by -$207.00 K (-3.44%)
What is Enliven Therapeutics TTM SGA?
The current TTM SGA of ELVN is -$749.06 M
What is the all time high TTM SGA for Enliven Therapeutics?
Enliven Therapeutics all-time high TTM SGA is -$45.20 M
What is Enliven Therapeutics TTM SGA year-on-year change?
Over the past year, ELVN TTM SGA has changed by -$769.50 M (-3765.76%)